Tecfidera Sales Data

Rank 32 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Tecfidera U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 32 (5) 20.28% 16.49%
Q3 2013 37 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
October 4, 2013Tecfidera Offers a Wide Range of Benefits in MS
March 28, 2013Tecfidera Approved for Multiple Sclerosis
March 20, 2013US Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA (Dimethyl Fumarate)
Hide
(web4)